인공 고관절 치환술 시장 : 규모, 점유율, 성장, 업계 분석, 유형별, 용도별, 지역별 인사이트, 예측(2026-2034년)

Growth Factors of hip replacement Market

The global hip replacement market is experiencing steady growth driven by the increasing prevalence of osteoarthritis and a rapidly aging population. The market was valued at USD 8.40 billion in 2025, grew to USD 8.80 billion in 2026, and is projected to reach USD 13.76 billion by 2034. North America dominated the market with a 34.46% share in 2025, supported by strong healthcare infrastructure and favorable reimbursement policies.

Hip replacement, also known as hip arthroplasty, is a surgical procedure that replaces damaged hip joints with artificial implants to restore mobility and reduce pain. The growing burden of joint-related disorders and increasing awareness about advanced treatment options are significantly contributing to market expansion.

Market Trends

One of the key trends shaping the market is the increasing awareness of hip replacement procedures and post-operative care. Patients are increasingly relying on digital platforms and mobile applications for recovery guidance and communication with healthcare providers. The integration of digital tools is improving patient outcomes and boosting confidence in surgical procedures.

Additionally, the adoption of robotic-assisted surgeries is gaining momentum. Advanced robotic systems enhance surgical precision, reduce recovery time, and improve implant positioning. The growing use of such technologies is transforming traditional orthopedic procedures and driving innovation in the market.

Market Drivers

The rising prevalence of osteoarthritis is a major driver of the hip replacement market. According to global health data, nearly 70% of individuals aged above 55 years are affected by osteoarthritis, significantly increasing the demand for hip implants. The condition leads to severe joint damage and pain, necessitating surgical intervention in advanced stages.

Another key driver is the growing geriatric population worldwide. Aging individuals are more prone to joint disorders, increasing the number of hip replacement procedures. Furthermore, improved healthcare access and favorable reimbursement policies, especially in developed countries, are encouraging patients to undergo surgeries. For instance, most hip replacement procedures are covered under major healthcare plans in the U.S., enhancing treatment accessibility.

The demand for customized hip implants is also contributing to market growth. The use of 3D printing technology enables the development of patient-specific implants, improving surgical outcomes and implant longevity.

Market Restraints

Despite strong growth prospects, the market faces challenges related to product recalls and legal issues. Defective implants can lead to complications such as infections, allergic reactions, and metal toxicity. These issues have resulted in numerous lawsuits against major manufacturers, impacting market confidence.

Additionally, the high cost of hip replacement procedures and implants can limit adoption in low- and middle-income countries. The need for skilled surgeons and advanced healthcare infrastructure further restricts market growth in developing regions.

Segmentation Analysis

By procedure, the total hip replacement segment dominates the market, accounting for 73.86% share in 2026. This dominance is attributed to the high number of total hip arthroplasty procedures performed globally and the increasing adoption of robotic-assisted surgeries.

Partial hip replacement and revision procedures are also witnessing growth due to the rising need for corrective surgeries and improved implant technologies.

By end-user, hospitals and ambulatory surgery centers (ASCs) hold the largest share, accounting for 72.96% in 2026, driven by the increasing number of surgical procedures and availability of advanced medical facilities. Orthopedic clinics are also growing steadily due to rising patient visits for joint-related treatments.

Regional Insights

North America leads the market with USD 2.9 billion in 2025 and is projected to reach USD 3.04 billion in 2026, driven by high procedure volumes and strong reimbursement systems. The U.S. remains the largest contributor due to advanced healthcare infrastructure and technological innovation.

Europe accounted for USD 2.18 billion in 2025 and is expected to reach USD 2.27 billion in 2026, supported by a high number of surgeries and favorable healthcare policies. Countries such as Germany perform nearly 200,000 hip replacement surgeries annually, highlighting strong regional demand.

Asia Pacific is emerging as a high-growth region, valued at USD 1.92 billion in 2025 and projected to reach USD 2.03 billion in 2026, driven by improving healthcare infrastructure and increasing awareness. Latin America and the Middle East & Africa are witnessing moderate growth due to rising disease prevalence and healthcare investments.

Competitive Landscape

The market is highly competitive, with key players such as Zimmer Biomet, DePuy Synthes, and Stryker holding a significant share. These companies focus on product innovation, strategic collaborations, and expansion of distribution networks.

Recent developments include the introduction of robotic-assisted systems and advanced implant technologies. Companies are also investing in augmented reality and navigation systems to enhance surgical precision and outcomes.

Conclusion

The hip replacement market is projected to grow from USD 8.40 billion in 2025 to USD 13.76 billion by 2034, driven by the rising prevalence of osteoarthritis, increasing geriatric population, and advancements in surgical technologies. While challenges such as high costs and product recalls persist, ongoing innovations and expanding healthcare access are expected to support sustained long-term market growth.

Segmentation By Procedure

• Total
• Partial
• Revision & Hip Resurfacing

By End-user

• Hospitals & ASCs
• Orthopedic Clinics
• Others

By Geography

• North America (By Procedure, End-user, and Country)
  • U.S. (By Procedure)
  • Canada (By Procedure)
• Europe (By Procedure, End-user, and Country/Sub-region)
  • U.K. (By Procedure)
  • Germany (By Procedure)
  • France (By Procedure)
  • Italy (By Procedure)
  • Spain (By Procedure)
  • Scandinavia (By Procedure)
  • Rest of Europe (By Procedure)
• Asia Pacific (By Procedure, End-user, and Country/Sub-region)
  • China (By Procedure)
  • Japan (By Procedure)
  • India (By Procedure)
  • Australia (By Procedure)
  • Southeast Asia (By Procedure)
  • Rest of Asia Pacific (By Procedure)
• Latin America (By Procedure, End-user, and Country/Sub-region)
  • Brazil (By Procedure)
  • Mexico (By Procedure)
  • Rest of Latin America (By Procedure)
• Middle East & Africa (By Procedure, End-user, and Country/Sub-region)
  • GCC (By Procedure)
  • South Africa (By Procedure)
  • Rest of Middle East & Africa (By Procedure)

Table of Content

1. Introduction

• 1.1. Research Scope
• 1.2. Market Segmentation
• 1.3. Research Methodology
• 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

• 3.1. Market Drivers
• 3.2. Market Restraints
• 3.3. Market Opportunities
• 3.4. Market Trends

4. Key Insights

• 4.1. Number of Hip Replacement Procedures - by Key Countries, 2025
• 4.2. Regulatory Scenario - by Key Countries/Regions
• 4.3. Reimbursement Scenario - by Key Countries/Regions
• 4.4. Technological Advancements in Hip Replacement Market
• 4.5. Key Industry Developments (Mergers, Acquisitions, New Product Launches, etc.)
• 4.6. Impact of COVID-19 on the Market

5. Global Hip Replacement Market Analysis, Insights and Forecast, 2021-2034

• 5.1. Market Analysis, Insights and Forecast - By Procedure
  • 5.1.1. Total
  • 5.1.2. Partial
  • 5.1.3. Revision & Hip Resurfacing
• 5.2. Market Analysis, Insights and Forecast - By End-user
  • 5.2.1. Hospitals & ASCs
  • 5.2.2. Orthopedic Clinics
  • 5.2.3. Others
• 5.3. Market Analysis, Insights and Forecast - By Region
  • 5.3.1. North America
  • 5.3.2. Europe
  • 5.3.3. Asia Pacific
  • 5.3.4. Latin America
  • 5.3.5. Middle East & Africa

6. North America Hip Replacement Market Analysis, Insights and Forecast, 2021-2034

• 6.1. Market Analysis, Insights and Forecast - By Procedure
  • 6.1.1. Total
  • 6.1.2. Partial
  • 6.1.3. Revision & Hip Resurfacing
• 6.2. Market Analysis, Insights and Forecast - By End-user
  • 6.2.1. Hospitals & ASCs
  • 6.2.2. Orthopedic Clinics
  • 6.2.3. Others
• 6.3. Market Analysis, Insights and Forecast - By Country
  • 6.3.1. U.S.
    • 6.3.1.1. By Procedure
  • 6.3.2. Canada
    • 6.3.2.1. By Procedure

7. Europe Hip Replacement Market Analysis, Insights and Forecast, 2021-2034

• 7.1. Market Analysis, Insights and Forecast - By Procedure
  • 7.1.1. Total
  • 7.1.2. Partial
  • 7.1.3. Revision & Hip Resurfacing
• 7.2. Market Analysis, Insights and Forecast - By End-user
  • 7.2.1. Hospitals & ASCs
  • 7.2.2. Orthopedic Clinics
  • 7.2.3. Others
• 7.3. Market Analysis, Insights and Forecast - By Countries/ Sub-region
  • 7.3.1. U.K.
    • 7.3.1.1. By Procedure
  • 7.3.2. Germany
    • 7.3.2.1. By Procedure
  • 7.3.3. France
    • 7.3.3.1. By Procedure
  • 7.3.4. Spain
    • 7.3.4.1. By Procedure
  • 7.3.5. Italy
    • 7.3.5.1. By Procedure
  • 7.3.6. Scandinavia
    • 7.3.6.1. By Procedure
  • 7.3.7. Rest of Europe
    • 7.3.7.1. By Procedure

8. Asia Pacific Hip Replacement Market Analysis, Insights and Forecast, 2021-2034

• 8.1. Market Analysis, Insights and Forecast - By Procedure
  • 8.1.1. Total
  • 8.1.2. Partial
  • 8.1.3. Revision & Hip Resurfacing
• 8.2. Market Analysis, Insights and Forecast - By End-user
  • 8.2.1. Hospitals & ASCs
  • 8.2.2. Orthopedic Clinics
  • 8.2.3. Others
• 8.3. Market Analysis, Insights and Forecast - By Countries/ Sub-region
  • 8.3.1. Japan
    • 8.3.1.1. By Procedure
  • 8.3.2. China
    • 8.3.2.1. By Procedure
  • 8.3.3. India
    • 8.3.3.1. By Procedure
  • 8.3.4. Australia
    • 8.3.4.1. By Procedure
  • 8.3.5. Southeast Asia
    • 8.3.5.1. By Procedure
  • 8.3.6. Rest of Asia Pacific
    • 8.3.6.1. By Procedure

9. Latin America Hip Replacement Market Analysis, Insights and Forecast, 2021-2034

• 9.1. Market Analysis, Insights and Forecast - By Procedure
  • 9.1.1. Total
  • 9.1.2. Partial
  • 9.1.3. Revision & Hip Resurfacing
• 9.2. Market Analysis, Insights and Forecast - By End-user
  • 9.2.1. Hospitals & ASCs
  • 9.2.2. Orthopedic Clinics
  • 9.2.3. Others
• 9.3. Market Analysis, Insights and Forecast - By Countries/ Sub regions
  • 9.3.1. Brazil
    • 9.3.1.1. By Procedure
  • 9.3.2. Mexico
    • 9.3.2.1. By Procedure
  • 9.3.3. Rest of Latin America
    • 9.3.3.1. By Procedure

10. Middle East & Africa Hip Replacement Market Analysis, Insights and Forecast, 2021-2034

• 10.1. Market Analysis, Insights and Forecast - By Procedure
  • 10.1.1. Total
  • 10.1.2. Partial
  • 10.1.3. Revision & Hip Resurfacing
• 10.2. Market Analysis, Insights and Forecast - By End-user
  • 10.2.1. Hospitals & ASCs
  • 10.2.2. Orthopedic Clinics
  • 10.2.3. Others
• 10.3. Market Analysis, Insights and Forecast - By Countries/ Sub region
  • 10.3.1. South Africa
    • 10.3.1.1. By Procedure
  • 10.3.2. GCC
    • 10.3.2.1. By Procedure
  • 10.3.3. Rest of Middle East & Africa
    • 10.3.3.1. By Procedure

11. Competitive Analysis

• 11.1. Global Market Share Analysis (2025)
• 11.2. Company Profiles
  • 11.2.1. Zimmer Biomet
    • 11.2.1.1. Overview
    • 11.2.1.2. Products & Services
    • 11.2.1.3. SWOT Analysis
    • 11.2.1.4. Recent Developments
    • 11.2.1.5. Strategies
    • 11.2.1.6. Financials (Based on Availability)
  • 11.2.2. Medical Device Business Services, Inc. (Johnson & Johnson Services, Inc.)
    • 11.2.2.1. Overview
    • 11.2.2.2. Products & Services
    • 11.2.2.3. SWOT Analysis
    • 11.2.2.4. Recent Developments
    • 11.2.2.5. Strategies
    • 11.2.2.6. Financials (Based on Availability)
  • 11.2.3. Smith+Nephew
    • 11.2.3.1. Overview
    • 11.2.3.2. Products & Services
    • 11.2.3.3. SWOT Analysis
    • 11.2.3.4. Recent Developments
    • 11.2.3.5. Strategies
    • 11.2.3.6. Financials (Based on Availability)
  • 11.2.4. Stryker
    • 11.2.4.1. Overview
    • 11.2.4.2. Products & Services
    • 11.2.4.3. SWOT Analysis
    • 11.2.4.4. Recent Developments
    • 11.2.4.5. Strategies
    • 11.2.4.6. Financials (Based on Availability)
  • 11.2.5. Exactech, Inc.
    • 11.2.5.1. Overview
    • 11.2.5.2. Products & Services
    • 11.2.5.3. SWOT Analysis
    • 11.2.5.4. Recent Developments
    • 11.2.5.5. Strategies
    • 11.2.5.6. Financials (Based on Availability)
  • 11.2.6. Gruppo Bioimpianti s.r.l.
    • 11.2.6.1. Overview
    • 11.2.6.2. Products & Services
    • 11.2.6.3. SWOT Analysis
    • 11.2.6.4. Recent Developments
    • 11.2.6.5. Strategies
    • 11.2.6.6. Financials (Based on Availability)
  • 11.2.7. Conformis
    • 11.2.7.1. Overview
    • 11.2.7.2. Products & Services
    • 11.2.7.3. SWOT Analysis
    • 11.2.7.4. Recent Developments
    • 11.2.7.5. Strategies
    • 11.2.7.6. Financials (Based on Availability)
  • 11.2.8. MicroPort Scientific Corporation
    • 11.2.8.1. Overview
    • 11.2.8.2. Products & Services
    • 11.2.8.3. SWOT Analysis
    • 11.2.8.4. Recent Developments
    • 11.2.8.5. Strategies
    • 11.2.8.6. Financials (Based on Availability)
  • 11.2.9. B. Braun SE
    • 11.2.9.1. Overview
    • 11.2.9.2. Products & Services
    • 11.2.9.3. SWOT Analysis
    • 11.2.9.4. Recent Developments
    • 11.2.9.5. Strategies
    • 11.2.9.6. Financials (Based on Availability)